Journals / Toraks Dergisi / 2003 / Cilt: 4 - Sayı: 1

Serum lipid profile changes in asthma patients during acute attack and stable period

Astım hastalarının akut atak ve stabil dönemlerindeki serum lipid profili değişimleri

Pages
7–11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During acute attacks significant changes may occur in the lipid parameters of the asthmatic patients compared with the levels of serum lipid in the stable periods of this disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The increased inflamatory reaction in asthmatic patients is thought to be responsible for the changes in the lipid metabolism by affecting the pulmonary surfactant synthesis.
📊
Key Findings & Data:The serum lipid levels of 30 asthmatic patients with an acute attack were measured twice (at the 1st day of the attack and at the 21st day of the asthma therapy), while blood samples of 36 stable asthmatic patients who did not have any attack for the last 6 months and of 24 healthy controls were measured once.
💡
Conclusion & Impact:During acute attacks significant changes may occur in the lipid parameters of the asthmatic patients compared with the levels of serum lipid in the stable periods of this disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Astım · Lipidler · Lipoproteinler

Abstract

The increased inflamatory reaction in asthmatic patients is thought to be responsible for the changes in the lipid metabolism by affecting the pulmonary surfactant synthesis. In this study, serum total cholesterol, trigliseride, high density lipoprotein [HDL], low density lipoprotein [LDL], very low density lipoprotein [VLDL] profile changes in asthma patients were investigated during acute attacks and stable periods. The serum lipid levels of 30 asthmatic patients with an acute attack were measured twice (at the 1st day of the attack and at the 21st day of the asthma therapy), while blood samples of 36 stable asthmatic patients who did not have any attack for the last 6 months and of 24 healthy controls were measured once. Serum HDL level was found to be significantly higher during the acute attack (61.6±10.0 mg/dl), compared to the post attack period (51.1±9.4 mg/dl) and the levels measured in the stable asthma group (52.5±15.6 mg/dl) (p<0.05). Whereas serum trigliseride levels were found to be lower during the acute attack (124.1±84.8 mg/dl), compared to the post attack period (142±92 mg/dl) and the stable asthma group (162.9±95.4 mg/dl) (p<0.05). There was not any significant difference between the three groups with respect to serum total cholesterol, LDL and VLDL values. As a result, we observed that there was an increase in serum HDL levels and a decrease in serum trigliseride levels of asthma patients during acute attack. During acute attacks significant changes may occur in the lipid parameters of the asthmatic patients compared with the levels of serum lipid in the stable periods of this disease.

Özet

Astımlı hastalardaki artmış inflamatuar reaksiyonun, pulmoner surfaktan sentezini etkileyerek, lipid metabolizmasında değişikliklere neden olabileceği düşünülmektedir. Çalışmamızda, astım hastalarının akut atak ve stabil dönemlerindeki serum lipid profili değişikliklerinin (total kolesterol, trigliserid, yüksek dansiteli lipoprotein [HDL], düşük dansiteli lipoprotein [LDL], çok düşük dansiteli lipoprotein [VLDL]) araştırılması amaçlandı. Akut atakla başvuran 30 astımlı hastada başvuru günü ile tedavinin 21. gününde olmak üzere iki kez, altı aydır atak görülmeyen stabil dönemdeki 36 astımlı hastada ve sağlıklı 24 kontrol olgusunda ise bir kez serum lipid profili düzeyleri ölçüldü. Astım akut atağıyla başvuran hastalarda atak sırasında ölçülen HDL düzeyleri (61.6±10.0 mg/dl), atak sonrası 21. güne (51.1±9.4 mg/dl) ve stabil astımlı gruba göre (52.5±15.6 mg/dl) daha yüksek saptandı (p<0.05). Akut atak sırasında ölçülen trigliserid düzeyleri ise (124.1±84.8 mg/dl), atak sonrası 21. gün (142±92 mg/dl) ve stabil gruba (162.9±95.4 mg/dl) göre daha düşük bulundu (p<0.05). Serum total kolesterol, LDL ve VLDL düzeyleri açısından üç grup arasında önemli fark izlenmedi.Sonuç olarak, astımlı hastaların atak dönemlerinde serum HDL'de yükselme ve trigliserid düzeylerinde düşme izledik. Astımlı hastalarda atak döneminde, stabil dönemlerine göre serum lipid parametrelerinde belirgin değişiklikler ortaya çıkabildiği gösterildi.

🔖

Cite This Article

ÇIKIRIKÇIOĞLU, Y. B., KÖMÜRCÜOĞLU, B., BİLAÇEROĞLU, S., AKPINAR, M., ÇELİKTEN, E. (2003). Serum lipid profile changes in asthma patients during acute attack and stable period. Toraks Dergisi, Cilt: 4 - Sayı: 1, 7–11. https://ajindex.com/articles/368117

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Global initiative for asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. National Heart, Lung, and Blood Institute Publication 1995;95:4659
  2. Kurashima K, Fujimura M, Matsuda T, Kobayashi T. Surface activity of sputum from acute asthmatic patient. Am J Respir Crit Care Med 1997;155:1254-9
  3. Hass MA, Longmore WJ. Regulation of lung surfactant cholesterol metabolism by serum lipoproteins. Lipids 1980;15:401-6
  4. Voyno-Yasenetskaya T, Dobbs LG, Erickson SK, Hamilton RL. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci 1993;90:4256-60
  5. Guthman F, Harrach-Ruprecht B, Looman AC. Interaction of lipoprotein with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol. Eur J Cell Biol 1997;74:197-207
  6. Pian MS, Dobbs LG. Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins. Am J Physiol 1997;273:L634-9
  7. Pasternak CA. İnsan Biyokimyasına Giriş. Ankara: Hacettepe Üniversitesi Yayınları; 1980:56-67
  8. Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 1997;10:482-91
  9. Boggaram V, Smitth JM, Mendelson CR. Posttranscriptinal regulation of surfactant protein- a messenger RNA in human fetal lung in vitro by glucocorticoids. Mol Endocrinol 1991;5:414-23
  10. Bernhard W, Muller B, Vonwichert P. Beta adrenergic primiting of rats in vivo modulates the effect of beta-agonist in vitro on surfactant phospholipid metabolism of isolated lung. Eur J Clin Invest 1994;24:393-9
  11. Shenoi A, Kumar L, Sarihyan S, Gangully N. High density lipoprotein cholesterol and total cholesterol in children with asthma and allergic rhinitis. Acta Paediatr 1992;81:150- 12) Pomerantz KB, Tall AR, Feinmark SJ, Cannon PJ. Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins. Circ Res 1984; 54:554-65
  12. Black PN, Sharpe S. Diatary fat and asthma: is there a connection? Eur Respir J 1997;10:6-10
  13. Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugena H, Harada S, Tanizaki Y. Effect of perilla seed oil supplementation on leukotriene generation by leucocytes in patients with asthma associated with lipometobolism. Int Arch Allergy Immunol 2000;122:137-42
  14. Floren CH, Kjellström T, Bauer CA. Bambuterol raises